No Data
TD Cowen Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $32
Jefferies Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $40
A Quick Look at Today's Ratings for Surgery Partners(SGRY.US), With a Forecast Between $31 to $50
Surgery Partners Third Quarter 2024 Earnings: EPS Misses Expectations
Surgery Partners Down Over 11%, on Pace for Largest Percent Decrease Since May 2022 -- Data Talk
Surgery Partners Price Target Lowered to $34 From $35 at Macquarie
Returns On Capital At Surgery Partners (NASDAQ:SGRY) Have Hit The BrakesNo Data
No Data
